The Framingham Heart Study is a project of Boston University & the National Heart, Lung, & Blood Institute.
The Framingham Heart Study is a project of Boston University & the National Heart, Lung, & Blood Institute.

Cardiovascular Disease
(30-year risk)

Based on
Pencina MJ, D’Agostino Sr RB, Larson MG, Massaro JM, Vasan RS. Predicting the thirty-year risk of cardiovascular disease: the Framingham Heart Study. Circulation. 2009 Jun 23;119:3078. PMID:19506114. PMCID:PMC2748236.

Outcome
“Hard” CVD (coronary death, myocardial infarction, stroke), “general” CVD (coronary death, myocardial infarction, coronary insufficiency, angina, ischemic stroke, hemorrhagic stroke, transient ischemic attack, peripheral artery disease, heart failure)

Duration of follow-up
Maximum of 35 years, 30-year risk prediction

Population of interest
Individuals 20 to 59 years and free of CVD and cancer at baseline examination

Predictors

  • Male Sex
  • Age
  • Systolic Blood Pressure (SBP)
  • Use of Antihypertensive treatment (yes/ no)
  • Smoking
  • Diabetes mellitus
  • Total cholesterol
  • HDL cholesterol
  • BMI replacing lipids in a simpler model

Risk Score Calculators

Interactive

Excel spreadsheets


×

30 Year Risk Factors

We acknowledge Mr. Aaron Vaneps and the Mayo Clinic Cardiovascular Health Clinic who provided the interactive risk calculator.

Sex: Male    Female
Systolic BP:
Age:
Diabetes:
Smoker:
Treated Hypertension:
Total Cholesterol:
HDL Cholesterol:
BMI:
Lipids-Based Results
Your Risk of Full CVD: %
Optimal Risk of Full CVD: %
Normal Risk of Full CVD: %
Your Risk of Hard CVD: %
Optimal Risk of Hard CVD: %
Normal Risk of Hard CVD: %
BMI-Based Results
Your Risk of Full CVD: %
Optimal Risk of Full CVD: %
Normal Risk of Full CVD: %
Your Risk of Hard CVD: %
Optimal Risk of Hard CVD: %
Normal Risk of Hard CVD: %